MedTrace Logo

Prevention of Delirium After Bone Marrow Transplantation

NCT01700816 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-06-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to find out if using bright light sessions during bone marrow transplant can prevent people from developing confusion also known as delirium.

Conditions

  • Delirium

Interventions

DEVICE

Bright light therapy

The light box will be placed vertically on a patient table or bed side 2.5 feet away from the user's eyes daily from 8 am to 8:30 am.

DEVICE

Sham light

The light box will be placed vertically on a patient table or bed side 2.5 feet away from the user's eyes daily from 8 am to 8:30 am.

Sponsors & Collaborators

  • American Cancer Society, Inc.

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Carlos Fernandez-Robles, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-09-30
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01700816 on ClinicalTrials.gov